Trial Profile
Adjuvant Imiquimod Therapy to Reduce Recurrence Rate in Patients After Surgical Therapy of Anal HPV (Human Papilloma Virus)-Lesions
Status:
Discontinued
Phase of Trial:
Phase III
Latest Information Update: 05 Nov 2021
Price :
$35
*
At a glance
- Drugs Imiquimod (Primary)
- Indications Condylomata acuminata; Human papillomavirus infections
- Focus Therapeutic Use
- Acronyms AdAM-trial
- 19 Feb 2021 Status changed from to discontinued.
- 22 Sep 2020 Planned End Date changed from 31 May 2020 to 15 Nov 2024.
- 22 Sep 2020 Planned primary completion date changed from 31 Dec 2019 to 15 Nov 2024.